moderna - Search News

News

FDA expands approval of Moderna's RSV vaccine

ABC News on MSN · 14h

FDA expands approval of Moderna's RSV vaccine to some adults under age 60

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the disease.

USA TODAY · 1d

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS Newswire / June 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.

BioPharma Dive · 15h

Moderna wins FDA OK to widen use of RSV vaccine

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s been significantly impacted by the recent changes in FDA and HHS leadership.

18hon MSN

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...

8hon MSN

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding

The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...

2don MSN

Moderna Seeks Outside Investors to Fund Select Vaccine Trials

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

3d

‘People inside Moderna are afraid’: As the anti-vaccine climate intensifies, a big local firm has much to lose

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

1don MSN

Is it Time to Dump Your Shares of Moderna?

After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune ...

3d

What Sparked Moderna Stock Crash?

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

9d

Down 80%, Should You Buy the Dip on Moderna?

Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from ...

‘People inside Moderna are afraid’: As anti-vaccine climate intensifies, the company has much to lose

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results